Division of Vascular Surgery, Department of Surgery, Tampere University Hospital, Tampere, Finland.
Department of Forensic Medicine, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
J Vasc Surg. 2018 Jun;67(6):1902-1907. doi: 10.1016/j.jvs.2017.05.090. Epub 2017 Aug 26.
Increasing data supports the role of bacterial inflammation in adverse events of cardiovascular and cerebrovascular diseases. In our previous research, DNA of bacterial species found in coronary artery thrombus aspirates and ruptured cerebral aneurysms were mostly of endodontic and periodontal origin, where Streptococcus mitis group DNA was the most common. We hypothesized that the genomes of S mitis group could be identified in thrombus aspirates of patients with lower limb arterial and deep venous thrombosis.
Thrombus aspirates and control blood samples taken from 42 patients with acute or acute-on-chronic lower limb ischemia (Rutherford I-IIb) owing to arterial or graft thrombosis (n = 31) or lower limb deep venous thrombosis (n = 11) were examined using a quantitative real-time polymerase chain reaction to detect all possible bacterial DNA and DNA of S mitis group in particular. The samples were considered positive, if the amount of bacterial DNA in the thrombus aspirates was 2-fold or greater in comparison with control blood samples.
In the positive samples the mean difference for the total bacterial DNA was 12.1-fold (median, 7.1), whereas the differences for S mitis group DNA were a mean of 29.1 and a median of 5.2-fold. Of the arterial thrombus aspirates, 57.9% were positive for bacterial DNA, whereas bacterial genomes were found in 75% of bypass graft thrombosis with 77.8% of the prosthetic grafts being positive. Of the deep vein thrombus aspirates, 45.5% contained bacterial genomes. Most (80%) of bacterial DNA-positive cases contained DNA from the S mitis group. Previous arterial interventions were significantly associated with the occurrence of S mitis group DNA (P = .049, Fisher's exact test).
This is the first study to report the presence of bacterial DNA, predominantly of S mitis group origin, in the thrombus aspirates of surgical patients with lower limb arterial and deep venous thrombosis, suggesting their possible role in the pathogenesis of thrombotic events. Additional studies will, however, be needed to reach a final conclusion.
越来越多的数据支持细菌炎症在心血管和脑血管疾病不良事件中的作用。在我们之前的研究中,在冠状动脉血栓抽吸物和破裂的脑动脉瘤中发现的细菌物种的 DNA 主要来自牙髓和牙周,其中变形链球菌组 DNA 最为常见。我们假设链球菌组的基因组可以在下肢动脉和深静脉血栓形成患者的血栓抽吸物中被识别。
采用实时定量聚合酶链反应检测 42 例因动脉或移植物血栓形成(n=31)或下肢深静脉血栓形成(n=11)而出现急性或急性慢性下肢缺血(Rutherford I-IIb)的患者的血栓抽吸物和对照血样,以检测所有可能的细菌 DNA 和特别是链球菌组的 DNA。如果血栓抽吸物中的细菌 DNA 量与对照血样相比增加 2 倍或更多,则认为样本为阳性。
在阳性样本中,总细菌 DNA 的平均差异为 12.1 倍(中位数为 7.1),而链球菌组 DNA 的差异为平均 29.1 倍和中位数 5.2 倍。动脉血栓抽吸物中,57.9%的细菌 DNA 阳性,而旁路移植物血栓形成中细菌基因组发现于 75%的病例中,其中 77.8%的假体移植物阳性。深静脉血栓抽吸物中,45.5%含有细菌基因组。在大多数(80%)细菌 DNA 阳性病例中,含有链球菌组 DNA。以前的动脉干预与链球菌组 DNA 的发生显著相关(P=0.049,Fisher 精确检验)。
这是第一项报告外科下肢动脉和深静脉血栓形成患者血栓抽吸物中存在细菌 DNA 的研究,主要来源于链球菌组,表明其可能在血栓形成事件的发病机制中起作用。然而,还需要进一步的研究来得出最终结论。